Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00446160 · ClinicalTrials.gov registry record
Adult Congenital Heart Disease Surgery
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 700
- Enrollment target
NCT00446160: Completed study, sponsored by Emory University.
NCT00446160 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 700 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00446160 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 700 participants
- Enrollment target
Study Summary
It is now estimated that the number of adults with congenital heart disease in the U.S is over 800,000. Unfortunately, these patients, in some way, have become a lost population. They have congenital abnormalities familiar to a children's hospital, yet have surpassed the age cutoff for admission. Recently, we have developed a specialized program to care for this unique patient population. Dedicated programs such as ours hope to optimize patient care, consolidate specialized resources, provide sufficient patient numbers for training and maintain expertise and facilitate research in this unique population.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2000-01 |
| Est. Completion | 2016-07-01 |
What the finished NCT00446160 record still lists
NCT00446160 is an observational study that tracks outcomes without assigning an intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00446160 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00446160 about?
NCT00446160 is a clinical study titled "Adult Congenital Heart Disease Surgery". It is now estimated that the number of adults with congenital heart disease in the U.S is over 800,000. Unfortunately, these patients, in some way, have become a lost population. They have congenital abnormalities familiar to a children's hospital, yet have surpassed the age cutoff for admission. R...
What is the current status of trial NCT00446160?
This trial is currently completed. The enrollment target is 700 participants. The study started on 2000-01. Estimated completion is 2016-07-01.
Who is sponsoring clinical trial NCT00446160?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900419 · 700 participants
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- NCT01804686 · 700 participants · Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- NCT02107989 · 700 participants
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
- NCT02129543 · 700 participants
Immune Reconstitution in Stem Cell Transplant Recipients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia